nVerses Capital’s Axcelis ACLS Stock Holding History

nVerses Capital’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100	Closed	-$11.2K	–	983
2024 Q1	$11.2K	Buy	+100	New	+$11.9K	0.03%	486

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

nVerses Capital's ACLS Position: Q2 2024 in Review

nVerses Capital sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 100 shares — an estimated $11.2K sold.

nVerses Capital first reported a position in ACLS in Q1 2024 and held it in 1 quarter. The position peaked at $11.2K in Q1 2024. 393 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

nVerses Capital reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
nVerses Capital sold 100 Axcelis shares in Q2 2024, an estimated $11.2K.
nVerses Capital first reported a position in Axcelis in Q1 2024 and held it in 1 quarter.
nVerses Capital's Axcelis position peaked at $11.2K in Q1 2024.
393 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.